GlaxoSmithKline LLC v. Anchen Pharmaceuticals Inc. et al
| GlaxoSmithKline LLC |
| Banner Pharmacaps Inc., Anchen Pharmaceuticals Inc. and Anchen Inc. |
| Anchen Pharmaceuticals Inc., Anchen Inc. and Banner Pharmacaps Inc. |
| GlaxoSmithKline LLC |
| 1:2011cv00046 |
| January 12, 2011 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Sue L. Robinson |
| Mary Pat Thynge |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
308
OPINION After Trial. Defendants have not proven by clear and convincing evidence that any of the asserted claims of the '467 Patent are invalid. GSK should submit an agreed-upon form of final judgment within two weeks (see Opinion for further details). Signed by Judge Richard G. Andrews on 8/9/2013. (nms)
|
|
Filing
243
Claim Construction OPINION. Signed by Judge Richard G. Andrews on 11/15/2012. (nms)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
